04/19/2024
3:21 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
5:41 PM | AULIN SHERRY (Reporting)
Xenon Pharmaceuticals (Issuer)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:42 PM | Von Seggern Christopher (Reporting)
Xenon Pharmaceuticals (Issuer)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:33 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:34 PM | DiFabio Andrea (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:35 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:37 PM | EMPFIELD JAMES R. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/12/2024
5:38 PM | KENNEY CHRISTOPHER JOHN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:09 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:47 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
4:27 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
4:28 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:31 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
6:03 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
6:04 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
3:10 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:12 AM | Avoro Capital Advisors LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
6:43 AM | DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/02/2024
3:41 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:04 PM | AZAB MOHAMMAD (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
8:50 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4/A | |
12/15/2023
4:38 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
7:02 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
4:05 PM | Xenon Pharmaceuticals (Filer)
| Form 424B5 | |
11/27/2023
6:03 AM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
3:27 PM | Svoronos Dawn (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/24/2023
3:33 PM | Svoronos Dawn (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
5:40 PM | Cannon Gillian (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/10/2023
5:56 PM | Cannon Gillian (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
6:00 PM | Gover Justin D. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/10/2023
6:05 PM | Gover Justin D. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
4:20 PM | Machado Patrick (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
4:21 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
4:22 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
4:24 PM | Svoronos Dawn (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
4:25 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
4:27 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
4:29 PM | AZAB MOHAMMAD (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
6:25 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The A.I. story nobody is telling you (Read ASAP) (Ad) There's been a lot of buzz surrounding A.I. over the past year...
Most of it is just hype and speculation.
But there's one recent A.I. development you NEED to hear about... Click here to see Louis' new video for yourself. |
06/01/2023
6:09 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2023
7:11 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2023
6:31 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/26/2023
6:10 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
6:05 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023
3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
